Sartorius Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | Outperform |
17
|
£121.10 | Buy/Sell | £165.99 | 34.64% | 16 | £187.73B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$595.30 | Buy/Sell | $591.94 | 4.15% | 1 | $227.24B |
| ROG | Roche Holding | Hold |
16
|
CHF237.10 | Buy/Sell | CHF307.83 | 14.93% | 9 | CHF191.28B |
| DHR | Danaher | Outperform |
10
|
$265.80 | Buy/Sell | $260.33 | 2.49% | 4 | $196.87B |
| MRK | Merck KGaA | Outperform |
18
|
167.20€ | Buy/Sell | 190.06€ | 9.45% | 4 | 72.69€B |
| PH | Parker-Hannifin Corp | Outperform |
10
|
$545.11 | Buy/Sell | $548.76 | 13.37% | 7 | $70.07B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$236.30 | Buy/Sell | $284.47 | 17.44% | 8 | $68.29B |
| A | Agilent Technologies | Outperform |
10
|
$154.23 | Buy/Sell | $138.82 | -2.09% | 10 | $45.20B |
| BIIB | Biogen | Outperform |
10
|
$230.57 | Buy/Sell | $299.62 | 25.12% | 13 | $33.57B |
| MTD | Mettler-Toledo International | Hold |
13
|
$1.52k | Buy/Sell | $1.12k | -12.66% | 0 | $32.52B |
| BAYN | Bayer | Hold |
5
|
28.58€ | Buy/Sell | 45.15€ | 4.97% | 4 | 28.08€B |
| STE | STERIS | Outperform |
13
|
$232.69 | Buy/Sell | $238.33 | 3.58% | 4 | $22.99B |
| ENTG | Entegris | Outperform |
18
|
$129.50 | Buy/Sell | $116.12 | 13.51% | 11 | $19.53B |
| RGEN | Repligen | Outperform |
16
|
$171.94 | Buy/Sell | $187.18 | 19.23% | 12 | $9.21B |
| GETI B | Getinge AB | Outperform |
18
|
kr185.50 | Buy/Sell | kr226.10 | 21.83% | 3 | kr63.33B |
| 3355 | Kuriyama Holdings | Outperform |
17
|
¥1.22k | Buy/Sell | ¥0.00 | 7.41% | 0 | ¥18.46B |